Chronic anemia in heart transplant patients: Prevalence, predisposing factors and prognostic significance;Anemia crónica en el trasplante cardiaco. Prevalencia, factores predisponentes y significado pronóstico

Revista Espanola de Cardiologia

Volumn 60, Issue 11, 2007, Pages 1144-1150

  Cursack, Guillermo C ^a,b,c   Crespo Leiro, María G ^a   Paniagua Martín, María J ^a   Muñiz, Javier ^b   Naya, Carmen ^a   Grille, Zulaika ^a   Rodríguez, José A ^a   Marzoa, Raquel ^a   Barge, Eduardo ^a   Ríos, Ramón ^a   Estévez, Francisco ^a   Cuenca, José J ^a   Juffé Stein, Alberto ^a   Castro Beiras, Alfonso ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

^c Instituto Cardiovascular de Rosario   (Argentina)

Author keywords

Anemia; Heart failure; Heart transplantation; Post heart transplantation complications

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATORVASTATIN; AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EVEROLIMUS; FERRIC HYDROXIDE SUCROSE; FLUINDOSTATIN; HEMOGLOBIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OKT 3; OMEPRAZOLE; PRAVASTATIN; PREDNISONE; RANITIDINE; RITUXIMAB; SIMVASTATIN; TARDYFERON; THYMOCYTE ANTIBODY;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DISEASE PREDISPOSITION; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREVALENCE; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; SURVIVAL;

EID: 37349033672     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13111786     Document Type: Article

References (31)

1. Hunt BJ, Amin S, Halil O, Yacoub M. The prevalence, course, and characteristics of chronic anemia after heart and lung transplantation. Transplantation. 1992;53:1251-6.
2. Embleton ND, O'Sullivan JJ, Hamilton JR, Dark JH, Summerfield GP. High prevalence of anemia after cardiac transplantation in children. Transplantation. 1997;64:1590-4.
3. Yorgin PD, Belson A, Sanchez J, Al Uzri AY, Sarwal M, Bloch DA, et al. Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis. 2002;40:1306-18.
4. MaheshwariA , Mishra R, Thuluvath PJ. Post-liver-transplant anemia: Etiology and management. Liver Transplant. 2004;10:165-73.
5. Gleissner CA, Murat A, Schafer S, Klingenberg R, Koch A, Remppis A, et al. Reduced hemoglobin after heart transplantation is no independent risk factor for survival but is associated closely with impaired renal function. Transplantation. 2004;77:710-7.
6. Müller HM, Horina JH, Kniepeiss D, Tripolt MB, Stadelbauer V, Schweiger M, et al. Characteristics and clinical relevance of chronic anemia in adult heart transplant recipients. Clin Transplant. 2001;15:343-8.
7. Zakliczynski M, Szewczyk M, Zakliczynska H, Zembala M. Clinical application of monitoring mycophenolic acid trough concentration in heart transplant recipients-single center's experience. Ann Transplant. 2005;10:38-45.
8. Gleissner CA, Klingenberg R, Staritz P, Koch A, Ehlermann P, Wiggenhauser A, et al. Role of erythropoietin in anemia after heart transplantation. Int J Cardiol. 2006;112:341-7.
9. Garrido IP, Crespo-Leiro MG, Paniagua MJ, Muñiz J, Vázquez-Rey E, Pérez-Fernández R, et al. Independent predictors of renal dysfunction after heart transplantation in patients with normal pretransplant renal function. J Heart Lung Transplant. 2005;24:1226-30.
10. Frost AE, Keller CA. Anemia and erythropoietin levels in recipients of solid organ transplants. The Multi-Organ Transplant group. Transplantation. 1993;56:1008-11.
11. Lupón J, Urrutia A, González B, Herreros J, Altimir S, Coll R, et al. Significado pronóstico de los valores de hemoglobina en pacientes con insuficiencia cardiaca. Rev Esp Cardiol. 2005;58:48-53.
12. Madjdpour C, Heindl V, Spahn DR. Risks, benefits, alternatives and indications of allogenic blood transfusions. Minerva Anestesiol. 2006;72:283-98.
13. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology. 2006;105:198-208.
14. Paniagua MJ, Crespo-Leiro MG, De la Fuente L, Tabuyo T, Mosquera I, Cañizares A, et al. Prevention of cytomegalovirus disease after heart transplantation: preemptive therapy with 7 days' intravenous ganciclovir. Transplant Proc. 2002;34:69-70.
15. Crespo-Leiro MG, Paniagua MJ, Mosquera I, Tabuyo T, De la Fuente L, Bouzas B, et al. Replacement of cyclosporine by tacrolimus for immunosuppression in heart transplant patients: safety and efficacy. Transplant Proc. 2002;34:113-4.
16. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24:1710-20.
17. Silverberg DS, Wexler D, Blum M, Laina A, Sheps D, Keren G, et al. Erythropoietin in heart failure. Semin Nephrol. 2005;25:397-403.
18. Szachniewicz J, Petruk-Kowalczyk J, Majda J, Kaczmarek A, Reczuch K, Kalra PR, et al. Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol. 2003;90:303-8.
19. Tang YD, Katz SD. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation. 2006;113:2454-61.
20. Goldsmith D, Al-Khoury S, Shah N, Covic A. Anaemia after renal transplantation - role of immunosuppressive drugs and a pathophysiological appraisal. Nephron Clin Pract. 2006;104:c69-74.
21. Shah N, Al-Khoury S, Afzali B, Covic A, Roche A, Marsh J, et al. Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors. Transplantation. 2006;81:1112-8.
22. Eisen HJ, Kobashigawa J, Keogh A, Bourge R, Renlund D, Mentzer R, et al. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant. 2005;24:517-25.
23. Kobashigawa J, Miller L, Renlund D, Mentzer R, Alderman E, Bourge R, et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Transplantation. 1999;68:708-9.
24. Khosroshahi HT, Asghari A, Estakhr R, Baiaz B, Ardalan MR, Shoja MM. Effects of azathioprine and mycophenolate mofetil-immunosuppressive regimens on the erythropoietic system of renal transplant recipients. Transplant Proc. 2006;38:2077-9.
25. Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, et al. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant. 2003;3:835-45.
26. Franklin TJ, Cook JM. The inhibition of nucleic acid synthesis by mycophenolic acid. Biochem J. 1969;113:515-24.
27. Wang K, Zhang H, Li Y, Wei Q, Li H, Yang Y, et al. Safety of mycophenolate mofetil versus azathioprine in renal transplantation: a systematic review. Transplant Proc. 2004;36:2068-70.
28. Gotloib L, Silverberg DS, Fudin R, Shostak A. Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron. J Nephrol. 2006;19:161-7.
29. Felker GM, Adams KF Jr, Gattis WA, O'Connor CM. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol. 2004;44:959-66.
30. Berry C, Norrie J, Hogg K, Brett M, Stevenson K, McMurray JJ. The prevalence, nature, and importance of hematologic abnormalities in heart failure. Am Heart J. 2006;151:1313-21.
31. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation. 2006;113:2713-23.